Results 91 to 100 of about 13,503 (207)

Toxicological and ecotoxicological risk‐based prioritization of pharmaceuticals in the natural environment [PDF]

open access: yes, 2016
Approximately 1500 active pharmaceutical ingredients are currently in use; however, the environmental occurrence and impacts of only a small proportion of these have been investigated.
Agerstrand   +37 more
core   +1 more source

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. [PDF]

open access: yes, 2015
BackgroundBudesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis.AimThe aim of ...
Barrett, Andrew C   +10 more
core   +3 more sources

The choice of treatment approach for mild and moderate ulcerative colitis: A review

open access: yesConsilium Medicum
Ulcerative colitis (UC) is a chronic immune-inflammatory disease of unknown etiology characterized by continuous non-granulomatous inflammation of the colon mucosa. Inflammation may be limited to the rectum but often extends to the proximal colon.
Oleg V. Golovenko   +2 more
doaj   +1 more source

The Role of Mesalamine in the Treatment of Ulcerative Colitis [PDF]

open access: yes, 2013
Ulcerative colitis (UC) is a chronic inflammatory condition of unclear etiology affecting the large bowel, most commonly the rectum and extending proximally in a continuous fashion. The overall principle in the pathophysiolgy of ulcerative colitis is the
Burakoff, Robert, Karagozian, Raffi
core  

Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. [PDF]

open access: yes, 2003
AIM: To explore the efficacy and safety of the topically acting steroid beclometasone dipropionate (BDP) in an oral controlled release formulation in the treatment of extensive or left-sided ulcerative colitis.
Adamo S   +12 more
core   +1 more source

Investigating the effects of combined treatment of mesalazine with Lactobacillus casei in the experimental model of ulcerative colitis

open access: yesFrontiers in Molecular Biosciences
IntroductionUlcerative colitis (UC), a common gastrointestinal disorder in affluent nations, involves chronic intestinal mucosal inflammation. This research investigated the effects of combined probiotic treatment of Lactobacillus casei (L.
Shabnam Bahrami   +4 more
doaj   +1 more source

Annular Lichen Planus in Association with Crohn Disease [PDF]

open access: yes, 2008
BACKGROUND: Lichen planus is an idiopathic inflammatory disease of the skin and mucous membranes. Although the etiology is not established, it has been associated with autoimmune diseases, viral infections, drugs and dental restoration materials. However,
Correia, S   +4 more
core   +1 more source

Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports [PDF]

open access: yes, 2007
Background Extraintestinal manifestations of Crohn's disease may involve the skin, the eyes, the genital mucosa, and the joints. Dermatoses associated with Crohn's disease include neutrophilic dermatoses, erythema nodosum, granulomatous dermatitis ...
Farhi David   +4 more
core   +2 more sources

Personalized AZithromycin/metronidAZole + dietary therapy in pediatric Crohn disease: Results of a pilot study

open access: yes
Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 4, Page 1051-1056, April 2026.
Charlotte M. Verburgt   +15 more
wiley   +1 more source

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis

open access: yesİstanbul Kuzey Klinikleri, 2018
INTRODUCTION[|]In this study,the effect of mesalazine was studied on TNF alpha IL-1 beta, IL-6, and C-reactive protein (CRP) levels and inflammatory changes in rat lungs with experimental peritonitis.[¤]METHODS[|]In total, 24 male Sprague–Dawley rats ...
Aziz Şener   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy